v3.25.2
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Mar. 31, 2023 $ 11 $ 53,524 $ (48,459) $ 5,076
Balance (in Shares) at Mar. 31, 2023 10,949      
Issuance of common stock in public offerings, net of fees and issuance costs $ 20 20,045 20,065
Issuance of common stock in public offerings, net of fees and issuance costs (in Shares) 20,552      
At-the-market sales of stock, net 278 278
At-the-market sales of stock, net (in Shares) 154      
Exercise of warrants $ 1 883 884
Exercise of warrants (in Shares) 719      
Shares issued for services 1 1
Shares issued for services (in Shares) 2      
Issuances under equity incentive plan 37 37
Issuances under equity incentive plan (in Shares) 88      
Stock-based compensation 2,664 2,664
Net loss (17,470) (17,470)
Balance at Mar. 31, 2024 $ 32 77,432 (65,929) 11,535
Balance (in Shares) at Mar. 31, 2024 32,464      
Issuance of common stock and warrants in private placements, net of fees and issuance costs $ 13 11,354 11,367
Issuance of common stock and warrants in private placements, net of fees and issuance costs (in Shares) 13,016      
Issuance of common stock and warrants in public offering, net of fees and issuance costs $ 6 7,338 7,344
Issuance of common stock and warrants in public offering, net of fees and issuance costs (in Shares) 5,451      
At-the-market sales of stock, net $ 1 2,113 2,114
At-the-market sales of stock, net (in Shares) 920      
Exercise of warrants $ 2 1,107 1,109
Exercise of warrants (in Shares) 1,719      
Shares issued for services 51 51
Shares issued for services (in Shares) 30      
Issuances under equity incentive plan 24 24
Issuances under equity incentive plan (in Shares) 106      
Stock-based compensation 2,357 2,357
Net loss (18,824) (18,824)
Balance at Mar. 31, 2025 $ 54 $ 101,776 $ (84,753) $ 17,077
Balance (in Shares) at Mar. 31, 2025 53,706